Concepedia

Publication | Open Access

Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib

DOIFull Paper Access

89

Citations

22

References

2019

Year

Haruki Uojima, Makoto Chuma, Yoshiaki Tanaka, Hisashi Hidaka, Takahide Nakazawa, Shogo Iwabuchi, Satoshi Kobayashi, Nobuhiro Hattori, Katsuaki Ogushi, Manabu Morimoto,
Liver Cancer

Abstract

Decreased skeletal muscle mass is associated with the occurrence of severe AEs and worse TTF and OS. Skeletal muscle mass can be used as a predictive marker for tolerability and prognosis to lenvatinib in patients with HCC.

References

YearCitations

Page 1